# KRBA2

## Overview
KRBA2 is a gene that encodes the protein KRAB-A domain containing 2, which is involved in transcriptional regulation. The protein is characterized by the presence of a zinc-finger Krüppel-associated box (KRAB) domain, known for its role in recruiting transcriptional repressor complexes, and an integrase (INT) domain derived from the GINGER2 superfamily of transposons (Llorens2012On). These structural features suggest that KRBA2 may play a role in transcriptional repression and possibly in ribosomal DNA silencing, akin to the yeast Fob1 protein (Srivastava2016The). The gene's expression has been linked to various biological processes and conditions, including its upregulation during the latent-to-lytic switch in Epstein-Barr virus infection and its potential involvement in cancer prognosis and leukemogenesis (BarreraRamirez2017MicroRNA; Frey2020Nascent; Yan2021Identifying). Despite these associations, the precise functions and mechanisms of KRBA2 in normal and pathological states remain to be fully elucidated.

## Structure
The KRBA2 protein is characterized by the presence of a zinc-finger Krüppel-associated box (KRAB) domain, which is typically involved in transcriptional repression by recruiting transcriptional repressor complexes (Llorens2012On). This domain precedes an integrase (INT) domain, which is derived from the GINGER2 superfamily of cut-and-paste transposons. These transposons are common in insects but are absent or extinct in vertebrates, suggesting an evolutionary adaptation in KRBA2 (Llorens2012On).

The molecular structure of KRBA2 lacks the hATd and SCAN domains found in the related SCAND3 gene, indicating a distinct structural composition (Llorens2012On). While the primary structure of KRBA2, which refers to its amino acid sequence, is not detailed in the context, the presence of the KRAB and integrase domains suggests a complex tertiary structure that facilitates its role in transcriptional regulation. The exact cellular function and potential post-translational modifications of KRBA2 remain unknown, as does information on any splice variant isoforms (Llorens2012On). The gene's presence in certain mammals and absence in others, such as some rodents, indicates lineage-specific variations in its structure and function (Llorens2012On).

## Function
The KRBA2 gene encodes a protein that plays a role in transcriptional regulation, primarily through its zinc-finger Krüppel-associated box (KRAB) domain. This domain is known for recruiting transcriptional repressor complexes, including histone deacetylases, which are involved in various cellular processes such as maintenance of the nucleolus, cell differentiation, cell proliferation, apoptosis, and neoplastic transformation (Llorens2012On). The KRBA2 protein is suggested to be involved in ribosomal DNA (rDNA) silencing, potentially acting as a homolog to the yeast Fob1 protein, which is involved in rDNA silencing by binding to replication fork barrier sites and recruiting other proteins (Srivastava2016The).

In the context of Epstein-Barr virus (EBV) infection, KRBA2 is upregulated during the latent-to-lytic switch, indicating a role in enhancing the susceptibility of latently infected cells to a lytic trigger. Knockdown of KRBA2 results in a reduction of ZEBRA-positive lytic cells, suggesting its involvement in the lytic cycle of EBV (Frey2020Nascent). However, the specific function of KRBA2 in healthy human cells remains largely undetailed in the available literature.

## Clinical Significance
The KRBA2 gene has been implicated in various diseases and conditions through alterations in its expression levels and interactions. In the context of bladder urothelial carcinoma (BLCA), KRBA2 is identified as a 'positive dark gene' due to its association with a good prognosis when linked to higher Immune Cell Infiltration (ICI) scores, despite not being differentially expressed (Yan2021Identifying). This suggests that KRBA2 plays a significant role in cancer prognosis, potentially serving as a biomarker for patient outcomes.

In acute myeloid leukemia (AML), KRBA2 has shown increased expression in AML-derived CD34-selected cells compared to controls. Although KRBA2 has not been previously associated with AML, this finding indicates a potential role in leukemogenesis, warranting further investigation into its impact on gene regulatory networks in leukemia (BarreraRamirez2017MicroRNA).

Additionally, KRBA2 has been mentioned in studies related to air pollution exposure, specifically PM 2.5, where it was identified among differentially expressed genes. However, the clinical significance of KRBA2 in this context remains unclear (Merid2021Integration). Overall, while KRBA2's role in disease is not fully understood, its expression and interactions suggest potential clinical relevance in certain conditions.

## Interactions



## References


[1. (Srivastava2016The) Rakesh Srivastava, Rashmi Srivastava, and Seong Hoon Ahn. The epigenetic pathways to ribosomal dna silencing. Microbiology and Molecular Biology Reviews, 80(3):545–563, September 2016. URL: http://dx.doi.org/10.1128/mmbr.00005-16, doi:10.1128/mmbr.00005-16. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mmbr.00005-16)

[2. (Llorens2012On) Carlos Llorens, Guillermo P. Bernet, Sukanya Ramasamy, Cedric Feschotte, and Andrés Moya. On the transposon origins of mammalian scand3 and krba2, two zinc-finger genes carrying an integrase/transposase domain. Mobile Genetic Elements, 2(5):205–210, September 2012. URL: http://dx.doi.org/10.4161/mge.22914, doi:10.4161/mge.22914. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/mge.22914)

[3. (Merid2021Integration) Simon Kebede Merid, Mariona Bustamante, Marie Standl, Jordi Sunyer, Joachim Heinrich, Nathanaël Lemonnier, Daniel Aguilar, Josep Maria Antó, Jean Bousquet, Loreto Santa-Marina, Aitana Lertxundi, Anna Bergström, Inger Kull, Åsa M. Wheelock, Gerard H. Koppelman, Erik Melén, and Olena Gruzieva. Integration of gene expression and dna methylation identifies epigenetically controlled modules related to pm2.5 exposure. Environment International, 146:106248, January 2021. URL: http://dx.doi.org/10.1016/j.envint.2020.106248, doi:10.1016/j.envint.2020.106248. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.envint.2020.106248)

[4. (Frey2020Nascent) Tiffany R. Frey, Jozan Brathwaite, Xiaofan Li, Sandeepta Burgula, Ibukun A. Akinyemi, Saurabh Agarwal, Eric M. Burton, Mats Ljungman, Michael T. McIntosh, and Sumita Bhaduri-McIntosh. Nascent transcriptomics reveal cellular prolytic factors upregulated upstream of the latent-to-lytic switch protein of epstein-barr virus. Journal of Virology, March 2020. URL: http://dx.doi.org/10.1128/jvi.01966-19, doi:10.1128/jvi.01966-19. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.01966-19)

[5. (BarreraRamirez2017MicroRNA) Juliana Barrera-Ramirez, Jessie R. Lavoie, Harinad B. Maganti, William L. Stanford, Caryn Ito, Mitchell Sabloff, Marjorie Brand, Michael Rosu-Myles, Yevgeniya Le, and David S. Allan. Micro-rna profiling of exosomes from marrow-derived mesenchymal stromal cells in patients with acute myeloid leukemia: implications in leukemogenesis. Stem Cell Reviews and Reports, 13(6):817–825, September 2017. URL: http://dx.doi.org/10.1007/s12015-017-9762-0, doi:10.1007/s12015-017-9762-0. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12015-017-9762-0)

[6. (Yan2021Identifying) Jinling Yan, Peiluan Li, Rong Gao, Ying Li, and Luonan Chen. Identifying critical states of complex diseases by single-sample jensen-shannon divergence. Frontiers in Oncology, June 2021. URL: http://dx.doi.org/10.3389/fonc.2021.684781, doi:10.3389/fonc.2021.684781. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.684781)